These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1282737)

  • 1. [Cultivated human vascular wall cells. A model for discovering potentially anti-arteriosclerosis active substances?].
    Roth D; Betz E
    Vasa Suppl; 1992; 35():125-7. PubMed ID: 1282737
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacologic inhibition of experimental atherosclerosis].
    Seuter F
    Z Kardiol; 1989; 78 Suppl 6():117-9. PubMed ID: 2618127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis.
    Karnovsky MJ; Wright TC; Castellot JJ; Choay J; Lormeau JC; Petitou M
    Ann N Y Acad Sci; 1989; 556():268-81. PubMed ID: 2525359
    [No Abstract]   [Full Text] [Related]  

  • 4. [Testing of proliferation modifying substances on cultivated blood vessel wall cells of the human].
    Roth D; Dartsch PC; Betz E
    Vasa Suppl; 1988; 23():27-30. PubMed ID: 3206344
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of heparin on vascular smooth muscle cells. II. Specific protein synthesis.
    Cochran DL; Castellot JJ; Karnovsky MJ
    J Cell Physiol; 1985 Jul; 124(1):29-36. PubMed ID: 2413048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor.
    Benitz WE; Lessler DS; Coulson JD; Bernfield M
    J Cell Physiol; 1986 Apr; 127(1):1-7. PubMed ID: 2420809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of smooth muscle proliferation by heparin in vitro and in vivo.
    Clowes AW; Clowes MM
    Int Angiol; 1987; 6(1):45-51. PubMed ID: 3624946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of dihematoporphyrin derivatives on cultivated human smooth muscle cells from normal and atherosclerotic vascular segments-- Overview of results and implications for photodynamic therapy].
    Dartsch PC; Betz E; Ischinger T
    Z Kardiol; 1991 Jan; 80(1):6-14. PubMed ID: 1827935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherogenic regulation by heparin-like molecules.
    Rosenberg RD; Reilly C; Fritze L
    Ann N Y Acad Sci; 1985; 454():270-8. PubMed ID: 3907466
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of intimal hyperplasia after arterial injury by heparins and heparinoid.
    Dryjski M; Mikat E; Bjornsson TD
    J Vasc Surg; 1988 Nov; 8(5):623-33. PubMed ID: 2460647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin, polycations, and atherosclerosis.
    Hyslop S; de Nucci G
    Semin Thromb Hemost; 1993; 19(2):89-98. PubMed ID: 8356463
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of diltiazem on plaque cells of primary and restenosed lesions].
    Voisard R; Dartsch PC; Bauriedel G; Höfling B; Betz E
    Vasa Suppl; 1989; 27():241-3. PubMed ID: 2623504
    [No Abstract]   [Full Text] [Related]  

  • 13. Human endothelial cells are stimulated and vascular smooth muscle cells are inhibited in their proliferation and migration by heparins.
    Hämmerle H; Betz E; Herr D
    Vasa; 1991; 20(3):207-15. PubMed ID: 1659056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium antagonists decrease migration and proliferation activity of human plaque monocytes].
    Heimerl J; Höfling B; Heidemann P; Emberger C; Kandolf R; Bauriedel G
    Vasa Suppl; 1992; 35():134-6. PubMed ID: 1481018
    [No Abstract]   [Full Text] [Related]  

  • 15. [Development of fibromuscular proliferation and atheroma in vitro as a therapeutic model].
    Betz E; Roth D; Wolburg-Buchholz K
    Vasa Suppl; 1990; 30():51-5. PubMed ID: 2075588
    [No Abstract]   [Full Text] [Related]  

  • 16. [The migration behavior of human vascular myocytes in culture--the screening potential of anti-arteriosclerosis active endogenous and exogenous substances].
    Bauriedel G; Ganesh S; Heimerl J; Brandl R; Becker HM; Höfling B
    Vasa Suppl; 1991; 33():147-8. PubMed ID: 1788649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heparin and the arterial wall].
    Manciet G; Decamps A; Bourdel I; Emeriau JP; Galley P
    Ann Cardiol Angeiol (Paris); 1991 Jun; 40(6):385-9. PubMed ID: 1859146
    [No Abstract]   [Full Text] [Related]  

  • 18. [The dynamics of blood vessel wall changes in the pathogenesis of arteriosclerosis].
    Kling D; Holzschuh T; Betz E
    Vasa Suppl; 1988; 23():11-4. PubMed ID: 3206328
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of heparinoid on the proliferation of rabbit vascular smooth muscle cells in vitro].
    He W; Zhou X; Xu H; Zhou X
    Yao Xue Xue Bao; 1998; 33(1):5-9. PubMed ID: 11938935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin suppresses sgk, an early response gene in proliferating vascular smooth muscle cells.
    Delmolino LM; Castellot JJ
    J Cell Physiol; 1997 Dec; 173(3):371-9. PubMed ID: 9369950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.